The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

When most people think about cancer treatment, they picture chemotherapy, grueling surgeries, harsh drug regimens, and devastating side effects. Medicus ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

New AI tool from UC San Diego and collaborators precisely maps the urethra on MRI to make prostate cancer radiation safer and reduce urinary side effects. Running on SDSC’s Expanse supercomputer, the ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...

Plastic particles were found at higher levels in tumor tissue than nearby noncancerous tissue, raising questions about the ...